Premium
Glucose transport inhibitors protect against 1,2‐cyclohexanedione‐produced potassium loss from human red blood cells
Author(s) -
Baker GF,
O'Gorman R,
Baker P
Publication year - 1998
Publication title -
experimental physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.925
H-Index - 101
eISSN - 1469-445X
pISSN - 0958-0670
DOI - 10.1113/expphysiol.1998.sp004108
Subject(s) - chemistry , phloretin , potassium , arginine , biochemistry , reagent , maltose , glucose transporter , transporter , endocrinology , biology , enzyme , amino acid , organic chemistry , insulin , gene
It has been suggested that the glucose transport system of human erythrocytes contains an arginine shield to prevent the leak of potassium through the transporter. To investigate this suggestion we treated human erythrocytes with the specific arginine reagent 1,2‐cyclohexanedione. Under conditions which produce a covalent reaction between arginine and the reagent, a steady leak of potassium occurs. If glucose, maltose or the inhibitor phloretin are present during the reaction the extent of the leak is reduced. These findings support the view that arginines have a role in preventing potassium loss through the glucose transporter.